Abstract:Introduction: β-Amyloid protein (Aβ) putatively plays a seminal role in synaptic loss in Alzheimer's disease (AD). While there is no consensus regarding the synaptic-relevant species of Aβ, it is known that Aβ oligomers (AβOs) are noticeably increased in the early stages of AD, localizing at or within the synapse. In cell and animal models, AβOs have been shown to attach to synapses and instigate synapse dysfunction and deterioration. To establish the pathological mechanism of synaptic loss in AD, it will be important to identify the synaptic targets to which AβOs attach.Methods: An unbiased approach using far western ligand blots has identified three synaptic proteins to which AβOs specifically attach. These proteins (p100, p140, and p260) were subsequently enriched by detergent extraction, ultracentrifugation, and CHT-HPLC column separation, and sequenced by LC-MS/MS. P100, p140, and p260 were identified. These levels of AβOs targets in human AD and aging frontal cortexes were analyzed by quantitative proteomics and western-blot. The polyclonal antibody to AβOs was developed and used to block the toxicity of AβOs. The data were analyzed with one-way analysis of variance.Results: AβOs binding proteins p100, p140, and p260 were identified as Na/K-ATPase, synGap, and Shank3, respectively. α3-Na/K-ATPase, synGap, and Shank3 proteins showed loss in the postsynaptic density (PSD) of human AD frontal cortex. In short term experiments, oligomers of Aβ inhibited Na/K-ATPase at the synapse. Na/K-ATPase activity was restored by an antibody specific for soluble forms of Aβ. α3-Na/K-ATPase protein and synaptic β-amyloid peptides were pulled down from human AD synapses by co-immunoprecipitation. Results suggest synaptic dysfunction in early stages of AD may stem from inhibition of Na/K-ATPase activity by Aβ oligomers, while later stages could hypothetically result from disrupted synapse structure involving the PSD proteins synGap and Shank3.Conclusion: We identified three AβO binding proteins as α3-Na/K-ATPase, synGap, and Shank3. Soluble Aβ oligomers appear capable of attacking neurons via specific extracellular as well as intracellular synaptic proteins. Impact on these proteins hypothetically could lead to synaptic dysfunction and loss, and could serve as novel therapeutic targets for AD treatment by antibodies or other agents.

Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

The Release and Transmission of Amyloid Precursor Protein Via Exosomes

Extracellular Vesicle-Associated Aβ Mediates Trans-Neuronal Bioenergetic and Ca2+-Handling Deficits in Alzheimer's Disease Models

Amyloid Β Oligomers Suppress Excitatory Transmitter Release Via Presynaptic Depletion of Phosphatidylinositol-4,5-bisphosphate

Amyloid-β Peptides Disrupt Interactions Between VAMP-2 and SNAP-25 in Neuronal Cells as Determined by FRET/FLIM

[Potential Involvement of Abnormal Increased SUMO-1 in Modulation of the Formation of Alzheimer's Disease Senile Plaques and Neuritic Dystrophy in APP/PS1 Transgenic Mice].

Ubiquitin Hydrolase Uch-L1 Rescues Β-Amyloid-induced Decreases in Synaptic Function and Contextual Memory

Specific Binding of Alzheimer's Aβ Peptides to Extracellular Vesicles

Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta

Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion

UBB+1 reduces amyloid-β cytotoxicity by activation of autophagy in yeast

Regulation of Neurotransmitter Release by Amyloid Precursor Protein Through Synapsin Phosphorylation

Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms

Differential Regulation of N-Methyl-D-Aspartate Receptor Subunits is an Early Event in the Actions of Soluble Amyloid-β(1-40) Oligomers on Hippocampal Neurons.

Reduced SUMOylation of Nrf2 signaling contributes to its inhibition induced by amyloid-β

Lys203 and Lys382 Are Essential for the Proteasomal Degradation of BACE1

Rab11A Depletion in Microglia-Derived Extracellular Vesicle Proteome upon Beta-Amyloid Treatment

APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ

Regulatory Role Of Golgi Brefeldin A Resistance Factor-1 In Amyloid Precursor Protein Trafficking, Cleavage And A Beta Formation

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease